References
- Palella FJ Jr, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med.338, 853–860 (1998).
- Hogg RS, Heath KV, Yip B et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA279(6), 450–454 (1998).
- Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature373(6510), 123–126 (1995).
- Ho DD. Time to hit HIV, early and hard. N. Engl. J. Med.333(7), 450–451 (1995).
- Harrington M, Carpenter CC. Hit HIV-1 hard, but only when necessary. Lancet355(9221), 2147–2152 (2000).
- Hogg RS, Yip B, Chan KJ et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA286(20), 2568–2577 (2001).
- Hammer SM, Squires KE, Hughes MD et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N. Engl. J. Med.337(11), 725–733 (1997).
- Mellors JW, Munoz A, Giorgi JV et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann. Intern. Med.126(12), 946–954 (1997).
- Egger M, May M, Chene G et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet360(9327), 119–129 (2002).
- May M, Sterne JA, Sabin C et al. Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS21(9), 1185–1197 (2007).
- Clumeck N, Pozniak A, Raffi F. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Med.9(2), 65–71 (2008).
- El Sadr WM, Lundgren JD, Neaton JD et al. CD4+ count-guided interruption of antiretroviral treatment. N. Engl. J. Med.355(22), 2283–2296 (2006).
Websites
- Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services 1–128 (2008) www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf
- Insight. START protocol nearing final approval www.cphiv.dk/portals/0/files/INSIGHT_feb_2008.pdf